Raia Drogasil SA Share Price Sao Paulo
Stocks
DROG3
BRDROGACNOR1
Drug Retailers
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - BRL | - |
|
| 21/05 | Brazil's GPA sells stake in Stix for 23 million reais, ends joint venture | RE |
| 07/05 | Raia Drogasil S.A., Q1 2026 Earnings Call, May 06, 2026 |
| Market Cap | 3.24TCr 633.97Cr 554.03Cr 511.24Cr 471.24Cr 888.2Cr 61TCr 907.91Cr 6.11TCr 2.4TCr 30TCr 2.38TCr 2.33TCr 1,02900Cr | P/E 2026 * |
21.7x | P/E 2027 * | 16x |
|---|---|---|---|---|---|
| Enterprise Value | 4.05TCr 791.65Cr 691.83Cr 638.4Cr 588.44Cr 1.11TCr 76TCr 1.13TCr 7.63TCr 3TCr 37TCr 2.97TCr 2.91TCr 1,28500Cr | EV / Sales 2026 * |
0.89x | EV / Sales 2027 * | 0.78x |
| Free-Float |
73.24% | Yield 2026 * |
1.95% | Yield 2027 * | 2.5% |
Last Transcript: Raia Drogasil SA
| Manager | Title | Age | Since |
|---|---|---|---|
Renato Raduan
CEO | Chief Executive Officer | 50 | 01/01/2025 |
| Director of Finance/CFO | 63 | 29/04/2013 | |
| Chief Tech/Sci/R&D Officer | - | 01/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 24/11/2011 | |
| Director/Board Member | 72 | 24/11/2011 | |
| Director/Board Member | 74 | 29/04/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.06% | +4.19% | -0.02% | +17.01% | 125.98Cr | |
| +0.14% | +2.01% | +7.04% | +21.40% | 48Cr | |
| -1.09% | -1.09% | -20.65% | +26.83% | 6.53Cr | |
| Average | +0.04% | +1.70% | -4.54% | +21.75% | 60.23Cr | |
| Weighted average by Cap. | +0.74% | +3.42% | +1.12% | +18.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.57TCr 893.13Cr 780.51Cr 720.23Cr 663.87Cr 1.25TCr 86TCr 1.28TCr 8.61TCr 3.39TCr 42TCr 3.35TCr 3.28TCr 1,45000Cr | 5.28TCr 1.03TCr 901.11Cr 831.51Cr 766.45Cr 1.44TCr 99TCr 1.48TCr 9.94TCr 3.91TCr 49TCr 3.87TCr 3.79TCr 1,67400Cr |
| Net income | 154.4Cr 30Cr 26Cr 24Cr 22Cr 42Cr 2.91TCr 43Cr 290.88Cr 114.41Cr 1.42TCr 113.33Cr 110.85Cr 4.9TCr | 207.51Cr 41Cr 35Cr 33Cr 30Cr 57Cr 3.91TCr 58Cr 390.94Cr 153.77Cr 1.91TCr 152.32Cr 148.98Cr 6.59TCr |
| Net Debt | 806.72Cr 157.68Cr 137.8Cr 127.15Cr 117.21Cr 220.91Cr 15TCr 225.81Cr 1.52TCr 597.78Cr 7.44TCr 592.17Cr 579.18Cr 26TCr | 888.72Cr 173.71Cr 151.8Cr 140.08Cr 129.12Cr 243.36Cr 17TCr 248.77Cr 1.67TCr 658.54Cr 8.19TCr 652.36Cr 638.05Cr 28TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- RADL3 Stock
- DROG3 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
